WebTop-Performing (over 17 years in the surgical device/pharmaceutical industry), National Oncology Market Development Manager, Oncology/Rare Disease Key Account Manager with Oncology Product Launch... Web8 dec. 2024 · The lack of approved therapies for AL and an absence of consensus treatment guidelines may be contributing to the disparate treatment approaches. Education to …
Doctor of Medicine /MD - Hematology and Oncology
Web7 dec. 2024 · A study was undertaken to assess hematologists/oncologists (hem/onc) ability to diagnose, monitor, refer, and manage patients with AL. Methods: An incentivized … Web23 nov. 2024 · From pre- to post-CG in the VPS, hem/oncs were significantly more likely to make evidence-based practice decisions across all learning objectives, see the Table. … data type character varying
Highpoint Cancer Center - Alliance Cancer Specialists
WebResults: A total of 2,035 learners participated in the activity and 218 hem/oncs answered all questions in the assessment. Hem/onc demographics and patient load distributions are … WebCreated as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about hundreds of hematology/oncology drugs, … Web13 jul. 2015 · Updates on New and Emerging Therapies for Neuroendocrine Tumors Jul 13, 2015 This case-based program is designed to educate medical oncologists, surgical oncologists, radiation oncologists, hem-oncs, and other allied health professionals on updates on new and emerging therapies for neuroendocrine tumors. Needs Statement bitter-sweetfarm.com